Evidence map›Paper›PMID 33102683›Full record

ReviewInternational journal of cardiology. Heart & vasculature2020

Central sleep apnea and atrial fibrillation: A review on pathophysiological mechanisms and therapeutic implications.

Alexandra M Sanchez, Robin Germany, Matthew R Lozier, Michael D Schweitzer, Semaan Kosseifi, Rishi Anand

Open access · goldAbstract readReview
In one paragraph

Review in International journal of cardiology. Heart & vasculature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Excessive Daytime Sleepiness and Risk of Sleep Apnea: A Retrospective Analysis of Peruvian Adults.Clinical practice and epidemiology in mental health : CP & EMH · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Observational
  7. Review
  8. Article
  9. Review
  10. Exploring the bidirectional relationship between sleep disorders and atrial fibrillation: implications for risk stratification and management.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Obstructive Sleep Apnea and Atrial Fibrillation.Journal of clinical medicine · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alexandra M SanchezUniversity of Miami at Holy Cross Hospital, Internal Medicine Residency Program, Ft Lauderdale, FL, USA.
Robin GermanyDivision of Cardiovascular Disease, University of Oklahoma, Respicardia Inc, Oklahoma City, OK, USA.
Matthew R LozierUniversity of Miami at Holy Cross Hospital, Internal Medicine Residency Program, Ft Lauderdale, FL, USA.
Michael D SchweitzerUniversity of Miami at Holy Cross Hospital, Internal Medicine Residency Program, Ft Lauderdale, FL, USA.
Semaan KosseifiPulmonary, Critical Care and Sleep Medicine, Holy Cross Hospital, Fort Lauderdale, FL, USA.
Rishi AnandCardiology, Jim Moran Heart and Vascular Research Institute, Holy Cross Hospital, Fort Lauderdale, FL, USA.
Holy Cross Hospital · USUniversity of Oklahoma · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precipitating factors and chronic diseases associated with atrial fibrillation (AF) are detailed in the literature. Emerging evidence over the last several decades suggests a potential causal relationship between central sleep apnea (CSA) and AF. Mechanisms including apnea-induced hypoxia with intermittent arousal, fluctuating levels of carbon dioxide, enhanced sympathetic/neurohormonal activation and oxidative stress causing inflammation have been implicated as etiologic causes of AF within this subpopulation. CSA affects the efficacy of pharmacologic and catheter-based antiarrhythmic treatments, which is why treating CSA prior to these interventions may lead to lower rates of AF. Subsequently, a reduction in the AF burden with transvenous phrenic nerve stimulation (TPNS) has become a topic of interest. The present review describes the relationship between these conditions, pathophysiologic mechanisms implicating the role of CSA in development of AF, and emerging therapeutic interventions.

Indexed as

Atrial fibrillationCentral sleep apneaPathophysiological mechanismsPhrenic nerve stimulationTherapeutic options

Identifiers

PMID33102683
PMCPMC7573647
OpenAlexW3026226360

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.